UNSPSC 85816213: Introduction of blood brain barrier disruption substance into peripheral vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of blood brain barrier disruption substance into peripheral vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E030GN

UNSPSC 85816213 Introduction of blood brain barrier disruption substance into peripheral vein, open approach is a Commodity code that shows no relevant recent state and local procurement activity. The code nominally describes an invasive medical procedure (blood-brain barrier disruption via peripheral vein injection), yet the most recent state and local opportunities posted under or associated with this code diverge sharply from that scope and do not substantiate purchasing or contracting for this specific clinical intervention. The recent-opportunities block contains forty-seven entries spanning virtual urgent care services, PACE operations, cancer registry services, retinal screening devices, EMS staffing, employee health clinics, occupational health services, psychological evaluation, wellness platforms, recovery audit contracting, nursing home placements, opioid use disorder treatment and recovery programs, behavioral health services, and other state and local health and social services spending—none of which aligns with the blood-brain barrier disruption procedure named in the code. This systematic mismatch indicates either a data-classification anomaly in the source material or that the code is being used incorrectly as a catch-all tag for unrelated health service procurements.

Without evidence of state and local demand for the specific medical procedure the code describes, this Commodity code presents no viable business-development target. Do not pursue activity under this code unless you can confirm that a specific soliciting body has posted an opportunity explicitly requesting blood-brain barrier disruption services or related neurointerventional clinical capabilities. The absence of even a single representative recent opportunity in the source materials is a decisive signal to watch or skip rather than pursue.